Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka V.C. & Janetka J.W. (2019). “Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.” Future Med Chem. 2019 Apr;11(7):743-769. doi: 10.4155/fmc-2018-0446. Epub 2019 Apr 4. (Abstract)

Sukrit is a graduate student in the Computational and Molecular Biophysics program. He is doing his PhD thesis work in the lab of Dr. Greg Bowman. Sukrit’s thesis is focused on understanding and exploiting allostery and dynamics in cellular signaling to develop anti-cancer therapeutics.